Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Central Role For Industry Beckons As Europe Rebuilds After COVID
Generics And Biosimilars Must Become A Central Policy Pillar, Says Rebecca Guntern
Oct 22 2021
•
By
David Wallace
Generics and biosimilars can help Europe to rebuild post-COVID • Source: Alamy
More from Policy & Regulation
More from Generics Bulletin